United Therapeutics reported $216.5M in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Acceleron Pharma XLRN:US $ -63.51M 0.05M
Alexion Pharmaceuticals ALXN:US $ 940.1M 164.6M
Amarin AMRN:US $ 8.87M 9.87M
Ardelyx ARDX:US $ -45.19M 12.03M
Arena Pharmaceuticals ARNA:US $ -146.1M 27.68M
Bayer BAYN:GR € 1537M 1825M
Biogen BIIB:US $ 814.2M 255M
Esperion Therapeutics ESPR:US $ -43668000 47.27M
GlaxoSmithKline GSK:LN 1482M 225M
Halozyme Therapeutics HALO:US $ 91.52M 36.81M
Insmed INSM:US $ -116699000 25.3M
Intercept Pharmaceuticals ICPT:US $ -11.09M 29.33M
Johnson & Johnson JNJ:US $ 8058M 282M
Moderna Inc MRNA:US 3.06B 1.8B
Omeros OMER:US $ -28593000 6.5M
Ptc Therapeutics PTCT:US $ -117.88M 10.31M
Regeneron Pharmaceuticals REGN:US $ 3898.3M 2658.7M
Sangamo Biosciences SGMO:US $ -47.15M 1.47M
Sarepta Therapeutics SRPT:US $ -81.76M 85.63M
Teva Pharmaceutical TEVA:IT 794M 650M
United Therapeutics UTHR:US $ 216.5M 184M